GGrantIndex
← Leaderboards

Valerie Humblet

Collagen Medical, Llc

$13,942,013
Attributed
$13,942,013
Total exposure
10
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $3.3M · FY201325
$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,942,013 · 10

By mechanism

R44$10,601,455 · 6
N43$1,713,052 · 1
N44$1,040,592 · 1
R43$586,914 · 2

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Collagen

Research focus

CollagenImageSignal TransductionBaseAffinityTissuesRattusMagnetic Resonance ImagingPeptidesCollagen Type IMedicalFibrosisSpecificityCessation Of LifeCyclic GmpTargeted ImagingSafetyMortalityDrug KineticsLiverMolecular ImagingAnimalsDoseToxic Effect

Grant awards (22)

Theranostic for gastric cancer$1,065,500
R44 · FY2025 · CA · contact PI
Theranostic for gastric cancer$885,123
R44 · FY2024 · CA · contact PI
PET imaging of radiation induced lung injury$805,334
R44 · FY2023 · CA · contact PI
Theranostic for gastric cancer$395,933
R44 · FY2023 · CA · contact PI
PET imaging of radiation induced lung injury$1,191,390
R44 · FY2022 · CA · contact PI
Targeted Imaging of Fibrosis in the Left Atrium$725,517
R44 · FY2022 · AG · contact PI
Targeted Imaging of Fibrosis in the Left Atrium$766,000
R44 · FY2021 · AG · contact PI
Molecular Imaging Agent to Detect Thrombus$496,849
R44 · FY2021 · HL · contact PI
New class of collagen-targeted contrast agents for Magnetic Resonance Imaging$287,065
R43 · FY2021 · EB · contact PI
PET imaging of radiation induced lung injury$399,990
R44 · FY2020 · CA · contact PI
Magnetic Particle Detection Test for Vulnerable Carotid Plaque$299,849
R43 · FY2019 · EB · contact PI
Targeted Imaging of Fibrosis in the Left Atrium$295,301
R44 · FY2018 · AG · contact PI
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer$209,717
R44 · FY2018 · CA · contact PI
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer$1,002,483
R44 · FY2017 · CA · contact PI
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer$997,515
R44 · FY2016 · CA · contact PI
CM-65, a Targeted Contrast Agent for Cardiac Magnetic Resonance Perfusion Imaging$430,152
R44 · FY2016 · HL · contact PI
IGF::OT::IGF SBIR TOPIC 85 TO SUPPORT THE DEVELOPMENT OF TARGET SPECIFIC MOLECULAR IMAGING AGENTS IN COMBINATION WITH EXISTING IMAGING MODALITIES TO DETECT HIGH RISK ATHEROSCLEROTIC PLAQUE.$1,499,276
N43 · FY2015 · HL · contact PI
IGF::OT::IGF MR Contrast Agent to Quantify Myocardial Fibrosis - SBIR Topic 072 -$1,040,592
N44 · FY2015 · HL · contact PI
CM-65, a Targeted Contrast Agent for Cardiac Magnetic Resonance Perfusion Imaging$427,371
R44 · FY2015 · HL · contact PI
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer$300,000
R44 · FY2015 · CA · contact PI
IGF::OT::IGF SBIR TOPIC 85 TO SUPPORT THE DEVELOPMENT OF TARGET SPECIFIC MOLECULAR IMAGING AGENTS IN COMBINATION WITH EXISTING IMAGING MODALITIES TO DETECT HIGH RISK ATHEROSCLEROTIC PLAQUE.$213,776
N43 · FY2014 · HL · contact PI
CM-65, a Targeted Contrast Agent for Cardiac Magnetic Resonance Perfusion Imaging$207,280
R44 · FY2013 · HL · contact PI